Uncategorized Archives - Page 3 of 86 - PsychedelicNewsWire (PNW)

MondayMay 22, 2023 12:06 pm

More Firms Enter Psychedelic Field to Develop Mental Health Treatments

Psychedelic reform is gaining traction in the United States as more states introduce measures to decriminalize and legalize the use of these substances. This is primarily due to a significant increase of interest in these drugs in the recent years as more studies uncover the therapeutic benefits that psychedelics possess. Thus far, numerous studies have found that psychedelics such as MDMA, psilocybin and ketamine may help manage symptoms of anxiety and depression, reduce OCD symptoms, improve mood and improve symptoms of post-traumatic stress disorder. In 2017, the FDA even granted breakthrough therapy designations to psychedelic therapies using psilocybin to treat…

ThursdayMay 18, 2023 3:19 pm

Five Scientific Discoveries about Psychedelic Substances, Their Effects

Interest in psychedelics has increased significantly in recent years, with numerous studies being conducted on DMT, MDMA, LSD and psilocybin mushrooms. These substances are known to alter cognition, perception and mood when consumed, with researchers finding that they also possess therapeutic benefits that may be useful in the treatment of mental health conditions such as anxiety, depression, addiction and PTSD. Today, we look at some of the discoveries related to psychedelic drugs and their therapeutic potential. Psychedelics may help manage alcohol abuse. One study has determined that a combination of 5-MeO-DMT and ibogaine treatments may help reduce symptoms of PTSD…

MondayMay 08, 2023 3:38 pm

Study Looks into Neurobiology of Psychedelics

Since the late 19th century, physicians have used laughing gas as an anesthetic. Laughing gas, or nitrous oxide as it is scientifically known as, was first discovered by Joseph Priestly, an English scientist in 1793. This colorless, odorless and nonflammable gas is known to produce mind-altering experiences when administered in small amounts, similar to states induced by psychedelics such as ketamine and LSD. New research has looked into how nitrous oxide affects brain activity and how similar its effects are to those of psychedelics. The study was led by Richard Harris and George Mashour of the Michigan Psychedelic Center at…

FridayApr 28, 2023 2:22 pm

Challenges Facing European Psychedelics Industry

Psychedelics are hallucinogenic drugs that induce temporary alterations in mood, perception and mental processes in an individual when ingested. These drugs can occur naturally, such as psilocybin, or be manufactured in a lab, such as LSD, which was first synthesized by Albert Hoffman in 1938. Before psychedelics were classified under Schedule 1 of the 1971 UN Convention on Psychotropic Drugs, the drugs were used to manage various symptoms and psychiatric issues. This classification was brought on mainly by the growing hostility of sociopolitical views regarding the use of drugs as well as the covert and unethical use of said drugs.…

TuesdayMar 28, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into the Feasibility of Using Ketamine Formulations as an Alternative Treatment for Fibromyalgia

Silo Pharma recently provided an update on an ongoing study delving into the potential use of SP-26 as an alternative treatment for fibromyalgia The study, which is being carried out in conjunction with Experimur, has looked into the feasibility of using a time-released, dosage-controlled formulation of ketamine as a suitable treatment for the chronic medical condition Since its founding, Silo Pharma has rapidly gained a reputation for its innovative approach towards seeking solutions to address a variety of underserved medical conditions Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced…

MondayMar 13, 2023 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression

A recent medical study found that psychedelic drugs showed promise as a treatment alternative for hard-to-treat depression Psychedelics were found to activate a greater number of serotonin 2A receptors then traditional antidepressant drugs, largely because of their ability to penetrated through cells’ fatty outer membranes The study reinforces the potential use of psychedelic drugs, and psilocybin in particular, as a treatment methodology for a variety of mental health related conditions Silo Pharma, a developmental stage biopharmaceutical company has long focused around merging traditional therapeutics with psychedelic research In a study carried out between 2013 to 2016, researchers found that 8.1%…

WednesdayFeb 22, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug approval pathway Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The…

MondayFeb 13, 2023 1:34 pm

Psychedelics Are Proving Their Mettle Against Trauma, Anxiety

The past two decades have been characterized by numerous drug reform initiatives that have resulted in controlled substances such as cannabis and psychedelics being recognized for their medical potential. While there has been a decent amount of research into cannabis thanks to loosening reforms across the country, psychedelic research is still in its infancy. Despite this limited research, hallucinogens have exhibited immense potential as treatments against a variety of mental health conditions in initial studies. The result has been a surge of research into the potential benefits and risks of using psychedelics to treat mental disorders such as depression, post-traumatic…

WednesdayFeb 08, 2023 1:18 pm

Australia First in Line to Categorize Psychedelics as Medicinal

Australia recently made history when it categorized psychedelics as medicines, becoming the first country in the world to grant the distinction to hallucinogenic drugs. Psychedelics have been subject to an increasing amount of research in recent years amid a rising push for alternative mental health treatments. Hallucinogenic drugs such as psilocybin and ketamine have exhibited a range of potential medical benefits against mental health disorders in a variety of clinical trials. However, the fact that these substances are largely illegal worldwide has hindered further research and made it nearly impossible for people who could benefit from psychedelic-assisted therapies to access…

ThursdayJan 26, 2023 12:26 pm

Legislators in More States are Filing Measures to Legalize Psychedelics

Lawmakers in three separate states have introduced legislation to legalize psychedelics in 2023, increasing the number of states in the Unite States that are considering psychedelic reform this session to more than a dozen. Recent research has revealed that psychedelic drugs such as psilocybin, ketamine and MDMA have the potential to treat mental health conditions with minimal side effects. Given that America is currently going through a mental health crisis and patients are increasingly reporting that psychiatric pharmaceutical medications aren’t always effective, interest in psychedelics as an alternative medication has skyrocketed. As more researchers across the country have launched studies…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized